Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2′,3′-dideoxycytidine

This publication has 30 references indexed in Scilit:

• Biologic Features of HIV-1 That Correlate with Virulence in the Host
  Science, 1988
• Molecular Pharmacologic Approaches to the Treatment of Aids
  Annual Review of Pharmacology and Toxicology, 1988
• RESUMPTION OF HIV ANTIGEN PRODUCTION DURING CONTINUOUS ZIDOVUDINE TREATMENT
  The Lancet, 1988
• PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)
  The Lancet, 1988
• Inhibition of Infectivity and Replication of HIV-2 and SIV in Helper T-Cells by 2′,3′-Dideoxynucleosides In Vitro
  AIDS Research and Human Retroviruses, 1988
• Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS
  Journal of Medical Virology, 1986
• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1986
• Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS
  Nature, 1986
• The Epidemiology of AIDS: Current Status and Future Prospects
  Science, 1985
• Effects of 2′,3′‐dideoxynucleosides on mammalian cells and viruses
  Journal of Cellular Physiology, 1984